Self-Reported Pharmacological Cognitive Enhancement Among Orthopaedic Surgeons in Türkiye: A Cross-Sectional Survey of Use Patterns, Academic Motivation, and Ethical Perceptions
This cross-sectional survey of 160 orthopaedic surgeons in Türkiye reveals that 15.6% reported lifetime use of cognitive-enhancing drugs, a behavior significantly associated with higher drug knowledge, academic career goals, and lower ethical perceptions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human mind is a powerful tool, but like any tool, it has limits. In high-stakes professions, where a single moment of distraction can have serious consequences, the pressure to stay sharp is immense. For decades, scientists have studied how healthy people try to push past those limits using pills designed to treat attention disorders or sleepiness. These substances, often called cognitive enhancers, are meant to help the brain focus, stay awake, and process information faster. While much of the research has focused on students cramming for exams, a quieter question has remained: what about the doctors who perform complex surgeries? These professionals face long hours, intense mental loads, and the constant need for precision. If they are turning to these drugs to get through their shifts, it raises questions not just about safety, but about the ethics of altering the mind for professional gain.
A recent study set out to explore this hidden landscape among orthopedic surgeons in Turkey. The researchers, a team from several universities and hospitals, wanted to know how many of these specialists had ever used such drugs, why they might have done so, and what they thought about the morality of the practice. They surveyed 160 physicians who work in orthopedics and trauma, asking them to answer anonymously about their lifetime use of these substances, their career goals, and their personal views on the ethics of taking them. The goal was not to judge, but to understand the patterns behind the behavior and see if certain types of doctors were more likely to use these aids than others.
The results revealed that cognitive enhancement is not an isolated phenomenon in this group. About one in six of the surveyed surgeons, or 15.6 percent, admitted to having used a cognitive-enhancing drug at some point in their lives. The most common substance reported was methylphenidate, a medication typically prescribed for attention deficit disorders. Most of these doctors did not take the drugs daily; instead, they used them during specific high-pressure times, such as before a major exam or during a particularly demanding period of work. The primary reason given was to improve focus and attention, followed by a desire to boost academic productivity. While the majority obtained these medications through a prescription, a significant portion relied on recommendations from friends or colleagues, or found other ways to access them without a doctor's direct order.
What stood out most in the data was the connection between a surgeon's mindset and their likelihood of using these drugs. The study found that doctors who had a clear goal of pursuing an academic career—such as becoming a professor or leading research—were far more likely to have used these substances. Similarly, those who simply knew more about these drugs were much more likely to have tried them. However, the picture was not entirely about ambition or knowledge. The researchers discovered that surgeons who used these drugs tended to have lower scores on a measure of ethical concern. In other words, those who had taken the pills were less likely to view the practice as ethically problematic compared to their colleagues who had never used them. Conversely, doctors who reported a strong, deep-seated motivation for their academic work were actually less likely to have used the drugs, suggesting that internal drive might be a protective factor against turning to chemical aids.
The study also highlighted that the environment in which a surgeon works might play a role. Those employed in private hospitals appeared to use these drugs more frequently than those in public or university settings, though the researchers noted this finding needs further confirmation with larger groups. Importantly, the study could not prove that one factor caused another. It remains unclear whether a low sense of ethical concern leads a doctor to take the drug, or if taking the drug changes their ethical views. It is also unknown whether the pressure of an academic career forces doctors to use these substances, or if those who are already inclined to use them are simply more likely to aim for academic roles.
Despite these unanswered questions, the findings paint a clear picture of a behavior that is more complex than simple performance enhancement. The use of these drugs among Turkish orthopedic surgeons appears to be a multidimensional issue tied to how doctors view their careers, their knowledge of the substances, and their personal ethical compass. The fact that most use is occasional and tied to specific demands suggests that these doctors are not necessarily dependent on the drugs, but are using them as a tool to manage intense periods of work and study. As the medical field continues to grapple with the demands of modern practice, understanding these patterns is a crucial first step. The study suggests that while the desire to be sharper is universal, the decision to use a pill to achieve it is deeply personal, shaped by a mix of professional ambition, ethical belief, and the specific pressures of the job.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.